Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia

Detalles Bibliográficos
Autores principales: Jensen, Christopher E., Montgomery, Nathan D., Galeotti, Jonathan, Foster, Matthew C., Zeidner, Joshua F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753433/
https://www.ncbi.nlm.nih.gov/pubmed/36444394
http://dx.doi.org/10.1111/jcmm.17608
_version_ 1784850962091868160
author Jensen, Christopher E.
Montgomery, Nathan D.
Galeotti, Jonathan
Foster, Matthew C.
Zeidner, Joshua F.
author_facet Jensen, Christopher E.
Montgomery, Nathan D.
Galeotti, Jonathan
Foster, Matthew C.
Zeidner, Joshua F.
author_sort Jensen, Christopher E.
collection PubMed
description
format Online
Article
Text
id pubmed-9753433
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97534332022-12-19 Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia Jensen, Christopher E. Montgomery, Nathan D. Galeotti, Jonathan Foster, Matthew C. Zeidner, Joshua F. J Cell Mol Med Short Communication John Wiley and Sons Inc. 2022-11-28 2022-12 /pmc/articles/PMC9753433/ /pubmed/36444394 http://dx.doi.org/10.1111/jcmm.17608 Text en © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Jensen, Christopher E.
Montgomery, Nathan D.
Galeotti, Jonathan
Foster, Matthew C.
Zeidner, Joshua F.
Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
title Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
title_full Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
title_fullStr Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
title_full_unstemmed Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
title_short Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
title_sort clinical and molecular features of flt3 juxtamembrane domain missense mutations in acute myeloid leukaemia
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753433/
https://www.ncbi.nlm.nih.gov/pubmed/36444394
http://dx.doi.org/10.1111/jcmm.17608
work_keys_str_mv AT jensenchristophere clinicalandmolecularfeaturesofflt3juxtamembranedomainmissensemutationsinacutemyeloidleukaemia
AT montgomerynathand clinicalandmolecularfeaturesofflt3juxtamembranedomainmissensemutationsinacutemyeloidleukaemia
AT galeottijonathan clinicalandmolecularfeaturesofflt3juxtamembranedomainmissensemutationsinacutemyeloidleukaemia
AT fostermatthewc clinicalandmolecularfeaturesofflt3juxtamembranedomainmissensemutationsinacutemyeloidleukaemia
AT zeidnerjoshuaf clinicalandmolecularfeaturesofflt3juxtamembranedomainmissensemutationsinacutemyeloidleukaemia

Ejemplares similares